Ardelyx (ARDX) EBITDA Margin (2013 - 2026)

Ardelyx (ARDX) reported EBITDA Margin of 40.15% for Q1 2026, up 1542.0% on a YoY basis from 2.44% in Q1 2025, and down 14995.69% quarter-over-quarter from 0.27% in Q4 2025.

Ardelyx (ARDX) EBITDA Margin (2013 - 2026) Analysis & Trends

Ardelyx has reported EBITDA Margin for 12 years, with the latest figure at 40.15% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 1542.0% year-over-year to 40.15%; the trailing twelve-month figure through Mar 2026 stood at 18.15% (down 329.0% YoY), and the FY2025 full-year result was 15.09%, down 331.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 40.15%, down from 0.27% in the prior quarter.
  • The five-year high for EBITDA Margin was 24.34% in Q4 2022, with the low at 6015.6% in Q1 2022.
  • Historically, EBITDA Margin has averaged 477.53% across 5 years, with a median of 40.15% in 2026.
  • Annual changes were most pronounced in 2022 — EBITDA Margin plunged 551183 bps — and 2023, when it surged 578041 bps.
  • Ardelyx's EBITDA Margin stood at 24.34% in 2022, then plunged by 439 bps to 82.58% in 2023, then soared by 105 bps to 3.89% in 2024, then sank by 107 bps to 0.27% in 2025, then slumped by 14996 bps to 40.15% in 2026.
  • The last three EBITDA Margin figures came in at 40.15% (Q1 2026), 0.27% (Q4 2025), and 23.74% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn -40.15%

Historic Data

Download Data
DateValue
Mar 31, 2026 -40.15%
Dec 31, 2025 -0.27%
Sep 30, 2025 -23.74%
Jun 30, 2025 -19.59%
Mar 31, 2025 -55.57%
Dec 31, 2024 3.89%
Sep 30, 2024 -0.53%
Jun 30, 2024 -22.58%
Mar 31, 2024 -58.15%
Dec 31, 2023 -82.58%
Sep 30, 2023 11.77%
Jun 30, 2023 -77.51%
Mar 31, 2023 -235.19%
Dec 31, 2022 24.34%
Sep 30, 2022 -459.25%
Jun 30, 2022 -1,067.26%
Mar 31, 2022 -6,015.60%
Dec 31, 2021 -3,522.16%
Sep 30, 2021 -3,715.94%
Jun 30, 2021 -3,440.82%